BENZONATATE capsule, liquid filled

Manufacturer
Stat Rx USA
Effective date
2009-10-27
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:07:51

Label at a glance#

ProductBenzonatate
Active ingredientBenzonatate
Label structure11 sections

Label contents#

Full prescribing information#

DESCRIPTION SECTION

Rx only

DESCRIPTION

Benzonatate, a non-narcotic antitussive agent, is 2, 5, 8, 11, 14, 17, 20, 23, 26-nonaoxaoctacosan-28-yl p-(butylamino) benzoate; with a molecular weight of 603.7.

Structure Image
Structure Image

Benzonatate Capsules, USP contain 100 mg or 200 mg of benzonatate, USP.

Benzonatate Capsules also contain: D and C Yellow No. 10, gelatin, glycerin, methylparaben sodium and propylparaben sodium.

CLINICAL PHARMACOLOGY SECTION

CLINICAL PHARMACOLOGY

Benzonatate acts peripherally by anesthetizing the stretch receptors located in the respiratory passages, lungs, and pleura by dampening their activity and thereby reducing the cough reflex at its source. It begins to act within 15 to 20 minutes and its effect lasts for 3 to 8 hours. Benzonatate has no inhibitory effect on the respiratory center in recommended dosage.

INDICATIONS & USAGE SECTION

INDICATIONS AND USAGE

Benzonatate acts peripherally by anesthetizing the stretch receptors located in the respiratory passages, lungs, and pleura by dampening their activity and thereby reducing the cough reflex at its source. It begins to act within 15 to 20 minutes and its effect lasts for 3 to 8 hours. Benzonatate has no inhibitory effect on the respiratory center in recommended dosage.

CONTRAINDICATIONS SECTION

CONTRAINDICATIONS

Hypersensitivity to benzonatate or related compounds.

WARNINGS SECTION

WARNINGS

Severe hypersensitivity reactions (including bronchospasm, laryngospasm and cardiovascular collapse) have been reported which are possibly related to local anesthesia from sucking or chewing the capsule instead of swallowing it. Severe reactions have required intervention with vasopressor agents and supportive measures.

PRECAUTIONS SECTION

PRECAUTIONS

Benzonatate is chemically related to anesthetic agents of the para-aminobenzoic acid class (e.g., procaine; tetracaine) and has been associated with adverse CNS effects possibly related to a prior sensitivity to related agents or interaction with concomitant medication.

Information for the Patient

Release of benzonatate from the capsule in the mouth can produce a temporary local anesthesia of the oral mucosa and choking could occur. Therefore, the capsules should be swallowed without chewing.

Usage in Pregnancy:
Pregnancy Category C.
Animal reproduction studies have not been conducted with benzonatate. It is also not known whether benzonatate can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Benzonatate should be given to a pregnant woman only if clearly needed.

Nursing Mothers:
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when benzonatate is administered to a nursing woman.

Carcinogenesis, Mutagenesis, Impairment of Fertility:
Carcinogenicity, mutagenicity, and reproduction studies have not been conducted with benzonatate.

Pediatric Use:
Safety and effectiveness in children below the age of 10 has not been established.

ADVERSE REACTIONS SECTION

ADVERSE REACTIONS

Potential Adverse Reactions to benzonatate may include:

Hypersensitivity reactions including bronchospasm, laryngospasm, cardiovascular collapse possibly related to local anesthesia from chewing or sucking the capsule.

CNS: sedation; headache; dizziness; mental confusion; visual hallucinations.

GI: constipation, nausea, GI upset.

Dermatologic: pruritus; skin eruptions.

Other: nasal congestion; sensation of burning in the eyes; vague “chilly” sensation; numbness of the chest; hypersensitivity.

Rare instances of deliberate or accidental overdose have resulted in death.

OVERDOSAGE SECTION

OVERDOSAGE

Overdose may result in death.

The drug is chemically related to tetracaine and other topical anesthetics and shares various aspects of their pharmacology and toxicology. Drugs of this type are generally well absorbed after ingestion.

Signs and Symptoms:
If capsules are chewed or dissolved in the mouth, oropharyngeal anesthesia will develop rapidly. CNS stimulation may cause restlessness and tremors, which may proceed to clonic convulsions followed by profound CNS depression.

Treatment:
Evacuate gastric contents and administer copious amounts of activated charcoal slurry. Even in the conscious patient, cough and gag refluxes may be so depressed as to necessitate special attention to protection against aspiration of gastric contents and orally administered materials. Convulsions should be treated with a short-acting barbiturates given intravenously and carefully titrated for the smallest effective dosage. Intensive support of respiration and cardiovascular-renal function is an essential feature of the treatment of severe intoxication from overdosage.

Do not use CNS stimulants.

DOSAGE & ADMINISTRATION SECTION

DOSAGE AND ADMINISTRATION

Adults and children over 10:

Usual dose is one 100 mg or 200 mg capsules t.i.d. as required. If necessary, up to 600 mg daily may be given.

HOW SUPPLIED SECTION

HOW SUPPLIED

Benzonatate Capsules, USP are available as:

Soft gelatin capsules, 100 mg (oval, yellow); bottle of 100

Imprint: A1.

NDC# 65162-536-10

Soft gelatin capsules, 100 mg (oval, yellow); bottle of 500

Imprint: A1.

NDC# 65162-536-50

Soft gelatin capsules, 200 mg (oblong, yellow); bottle of 100

Imprint: A2.

NDC# 65162-537-10

Store at 25°-25°C (68°-77°F) [See USP Controlled Room Temperature]. Dispense in tight, light-resistant container as defined in the USP.

Manufactured by:
Swiss Caps AG

Hausenstrasse 35

CH-9533, Kirchberg, Switzerland

Distributed by:

Amneal Pharmaceuticals

Glasgow, KY 42141

Rev. 09-2008

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Benzonatate 100mg Label

Label ImageLabel Image

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
197397benzonatate 100 MG Oral CapsulePSN1
197397benzonatate 100 MG Oral CapsuleSCD1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BENZONATATE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dc429dc2-e942-6686-8d72-b63c57e806aaProduct name520190416
d45c2ed6-126c-dd22-afd2-e29a2ecf77b9Product name320190215

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
16590-031-302019-10-21C16284748780-1956f9ecf-bdc9-621f-e053-dbdaa90a74adBENZONATATE capsule, liquid filled

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
16590-031-30Benzonatate30 in 1 BOTTLECAPSULE301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
16590-031BENZONATATE CAPSULE [STAT RX USA]11 package rows20100121_222b9299-255c-44b4-9b7a-b9e16e36fe99.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
16590-031-30EA - Each16590-031943dd7a3-4ca8-4606-8520-084e2cf57a6912012-07-24
65162-536-10EA - Each65162-536e6b6447b-edef-42fc-a471-38ef4db3be7312012-07-24
65162-536-50EA - Each65162-536c461518f-f944-41de-b640-8ed65c6de13d12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BenzonatateACTIVE INGREDIENT5P4DHS6ENR1
BenzonatateACTIVE MOIETY5P4DHS6ENR1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 1 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
16590-03116590-031-30
65162-536

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
Benzonatate5P4DHS6ENRACTIB

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A040682-001BENZONATATEBENZONATATE100MGCAPSULE / ORALAA2007-07-30
A040682-002BENZONATATEBENZONATATE200MGCAPSULE / ORALAA2007-07-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A040682-001AA
A040682-002AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 90 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-30d4dbc9d85df4…
2026-11-14 07:37:172026-10A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-30d4dbc9d85df4…
2026-10-15 13:18:302026-09A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-30c2088c7a36db…
2026-10-15 13:18:302026-09A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-30c2088c7a36db…
2026-09-14 22:38:342026-08A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-3084e616aacf4f…
2026-09-14 22:38:342026-08A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-3084e616aacf4f…
2026-08-18 06:07:402026-07A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-30caaa826d4ba7…
2026-08-18 06:07:402026-07A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-30caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-30011fe1cb6892…
2026-02-19 14:30 UTC2026-02A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-30011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-3031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-3031067a03dcf5…
2025-08-23 18:47 UTC2025-08A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-306a471c1ec25d…
2025-08-23 18:47 UTC2025-08A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-306a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-30fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-30fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-30b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-30b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-3003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-3003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-302680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-302680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-305bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-305bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-30d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-30d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-30d06236e962d9…
2024-10-29 15:01 UTC2024-10A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-30d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-3079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-3079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-30301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-30301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-301e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-301e350fbaab3a…
2024-05-31 18:47 UTC2024-05A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-308072bd15b7f6…
2024-05-31 18:47 UTC2024-05A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-308072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-305c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-305c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A040682-001BENZONATATE100MGCAPSULE / ORALAA2007-07-305d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A040682-002BENZONATATE200MGCAPSULE / ORALAA2007-07-305d02ea3f76ae…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 90 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A040682-001AA1d4dbc9d85df4…
2026-11-14 07:37:172026-10A040682-002AA1d4dbc9d85df4…
2026-10-15 13:18:302026-09A040682-001AA1c2088c7a36db…
2026-10-15 13:18:302026-09A040682-002AA1c2088c7a36db…
2026-09-14 22:38:342026-08A040682-001AA184e616aacf4f…
2026-09-14 22:38:342026-08A040682-002AA184e616aacf4f…
2026-08-18 06:07:402026-07A040682-001AA1caaa826d4ba7…
2026-08-18 06:07:402026-07A040682-002AA1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A040682-001AA1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A040682-002AA1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040682-001AA131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040682-002AA131067a03dcf5…
2025-08-23 18:47 UTC2025-08A040682-001AA16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A040682-002AA16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040682-001AA1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040682-002AA1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040682-001AA1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040682-002AA1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040682-001AA103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040682-002AA103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040682-001AA12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040682-002AA12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040682-001AA15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040682-002AA15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040682-001AA1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040682-002AA1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A040682-001AA1d06236e962d9…
2024-10-29 15:01 UTC2024-10A040682-002AA1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040682-001AA179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040682-002AA179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040682-001AA1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040682-002AA1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040682-001AA11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040682-002AA11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A040682-001AA18072bd15b7f6…
2024-05-31 18:47 UTC2024-05A040682-002AA18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040682-001AA15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040682-002AA15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A040682-001AA15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A040682-002AA15d02ea3f76ae…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BenzonatateBENZONATATEAmneal Pharmaceuticals LLC199a42ae-4d19-4e68-934d-dabd270849882024-10-23Boxed warning, Adverse reactionsExact identifier
ndc (product): 65162-536
b1166a9a-d484-4b4a-b251-299d7c3c3f0d222b9299-255c-44b4-9b7a-b9e16e36fe992009-10-27Warnings, Adverse reactionsExact identifier
spl id: b1166a9a-d484-4b4a-b251-299d7c3c3f0d
spl set id: 222b9299-255c-44b4-9b7a-b9e16e36fe99

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.